Immunic AG | WebDisclosure

BRIEF

published on 02/17/2026 at 22:10, 1 month 4 days ago

Immunic Secures Hefty Funding Through Oversubscribed Private Placement

Private Placement Biotechnology Multiple Sclerosis Trials Investor Participation Immunic Financing
PRESS RELEASE

published on 02/17/2026 at 22:05, 1 month 4 days ago

Immunic Announces Closing of Oversubscribed Private Placement Financing
Immunic closes oversubscribed private placement financing of USD 200 million with potential for additional USD 200 million, aiming to fund phase 3 ENSURE trials and transition to commercialization

Private Placement Biotechnology Financing Immunic ENSURE Trials
BRIEF

published on 02/13/2026 at 12:35, 1 month 9 days ago

Immunic lève 400 millions de dollars pour accélérer ses ambitions commerciales

Biotechnologie Placement Privé Sclérose En Plaques Changements De Direction Immunic AG
BRIEF

published on 02/13/2026 at 12:35, 1 month 9 days ago

Immunic Secures USD 400 Million to Advance Commercial Ambitions

Private Placement Biotechnology Leadership Changes Multiple Sclerosis Immunic AG
PRESS RELEASE

published on 02/13/2026 at 12:30, 1 month 9 days ago

Immunic Announces Oversubscribed Private Placement of up to USD 400 Million to Accelerate Transformation into Commercial-Stage Company
Immunic announces oversubscribed private placement of up to USD 400 million to accelerate transformation into commercial-stage company. New leadership appointments to propel growth

Private Placement Growth Leadership Immunic Commercial-stage
BRIEF

published on 02/04/2026 at 12:35, 1 month 18 days ago

Immunic dévoile des résultats prometteurs pour son essai de phase 2 sur le vidofludimus calcique

Vidofludimus Calcium Essai De Phase 2 Sclérose En Plaques Progressive Forum ACTRIMS 2026 Effets Antiviraux
BRIEF

published on 02/04/2026 at 12:35, 1 month 18 days ago

Immunic Unveils Promising Phase 2 Trial Results for Vidofludimus Calcium

Vidofludimus Calcium Phase 2 Trial Progressive Multiple Sclerosis ACTRIMS Forum 2026 Antiviral Effects
PRESS RELEASE

published on 02/04/2026 at 12:30, 1 month 18 days ago

Immunic to Present Additional Phase 2 CALLIPER Trial Data for Vidofludimus Calcium at the ACTRIMS Forum 2026, Reinforcing Its Potential in Progressive Multiple Sclerosis
Immunic to present additional Phase 2 CALLIPER Trial Data for Vidofludimus Calcium at the ACTRIMS Forum 2026, reinforcing potential in Progressive Multiple Sclerosis. Latest research findings to be shared at event

Immunic Vidofludimus Calcium Progressive Multiple Sclerosis Phase 2 CALLIPER Trial ACTRIMS Forum 2026
BRIEF

published on 01/07/2026 at 12:35, 2 months 15 days ago

Immunic Reviews 2025 Progress and Sets Sights on Future Goals

Vidofludimus Calcium Neuroprotection Multiple Sclerosis Trials Immunic Accomplishments Biotechnology Milestones
BRIEF

published on 01/07/2026 at 12:35, 2 months 15 days ago

Bilan d'Immunic 2025 : progrès et perspectives d'avenir

Vidofludimus Calcium Neuroprotection Essais Cliniques Sur La Sclérose En Plaques Réalisations Immunitaires Étapes Clés De La Biotechnologie

Published on 03/20/2026 at 23:00, 1 day 17 hours ago

Cypher Announces Private Placement
Published on 03/20/2026 at 21:30, 1 day 18 hours ago

Sky Gold Sets Options
Published on 03/20/2026 at 21:15, 1 day 18 hours ago

Earthwise Minerals Announces Private Placement
Published on 03/20/2026 at 13:30, 2 days 2 hours ago

Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock
Published on 03/20/2026 at 12:30, 2 days 3 hours ago

CANEX Metals Announces the Numbers of Gold Basin Shares Taken up by Canex Metals

View all ACCESSWIRE

Published on 03/22/2026 at 12:23, 3 hours 37 minutes ago

Borussia Dortmund and Sebastian Kehl are ending their collaboration with immediate effect
Published on 03/20/2026 at 22:45, 1 day 17 hours ago

Investor Alert: Berger Montague (Canada) PC represents investors that purchased shares of Super Micro Computer, Inc. listed on the CBOE Canada and elsewhere
Published on 03/20/2026 at 21:05, 1 day 18 hours ago

Fractal EMS Receives ISO/IEC 9001 and 27001 Certifications
Published on 03/20/2026 at 21:05, 1 day 18 hours ago

Nebius Group announces closing of private offering of convertible senior notes, with aggregate gross proceeds of approximately $4.3 billion
Published on 03/20/2026 at 21:00, 1 day 18 hours ago

BRP Unveils the Winners of its 6th International Design Challenge

View all EQS

Published on 03/20/2026 at 19:00, 1 day 21 hours ago

AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 1 day 21 hours ago

AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 1 day 21 hours ago

Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 1 day 21 hours ago

Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
Published on 03/20/2026 at 17:45, 1 day 22 hours ago

Cie du Bois Sauvage : Jaarverslag 2025

View all LES ECHOS COMFI WIRE

News